| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 02/05/2013 | CA2727986C Methods for obtaining cyclopamine |
| 01/31/2013 | WO2013016725A1 Progesterone antagonists |
| 01/31/2013 | US20130029953 Progesterone antagonists |
| 01/31/2013 | CA2846573A1 Progesterone antagonists |
| 01/30/2013 | CN102898495A Method for preparing abiraterone acetate |
| 01/30/2013 | CN102432662B Crystal form of pipecuronium bromide, preparation method and application of crystal form |
| 01/29/2013 | US8361996 Imidazolyl substituted steroidal and indan-1-one derivatives |
| 01/23/2013 | CN102887932A Preparation method of self-healing micro-molecular gel |
| 01/23/2013 | CN102353661B Fluorescent sensor film preparation method based on perylene diimide cholesterol derivative |
| 01/22/2013 | CA2683522C 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 01/17/2013 | US20130018027 Compositions and methods for non-toxic delivery of antiprogestins |
| 01/16/2013 | CN102875628A (20S,24S)-ocotillol ginsenoside derivatives with antibacterial activity, and preparation method and application thereof |
| 01/16/2013 | CN101906128B Estrone compound, as well as preparation method and application thereof |
| 01/10/2013 | US20130011340 Compositions and methods comprising magnetic resonance contrast agents |
| 01/09/2013 | CN102863499A Extraction method of solanum pseudo-capsicum alkaloids |
| 01/09/2013 | CN102863498A Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 01/03/2013 | WO2013000286A1 Bufogenin derivatives, preparation methods, compositions containing such derivatives and uses thereof |
| 01/03/2013 | US20130005697 Progesterone Receptor Antagonists |
| 01/03/2013 | US20130005696 Bufadienolide derivatives, preparing process thereof, composition comprising the same and the use thereof |
| 01/02/2013 | CN101291950B Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 12/26/2012 | CN102838649A Preparation method of abiraterone acetate |
| 12/25/2012 | US8338588 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 12/19/2012 | EP2534167A2 Progesterone receptor antagonists |
| 12/19/2012 | EP2534166A2 Progesterone receptor antagonists |
| 12/19/2012 | CN102834405A Progesterone receptor antagonists |
| 12/18/2012 | US8334280 Ligands of estrogen receptors α and β, method of their preparation, and pharmaceuticals comprising them |
| 12/18/2012 | CA2626627C Androsterone derivatives and method of use thereof |
| 12/13/2012 | US20120316145 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases |
| 12/12/2012 | CN102822190A Mammalian metabolites of steroids |
| 12/12/2012 | CN102816201A Purification method of abiraterone |
| 12/12/2012 | CN102816200A Method for preparing abiraterone acetate |
| 12/12/2012 | CN102816199A Preparation and detection method of abiraterone Acetate dimer compound |
| 12/06/2012 | US20120309730 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling |
| 12/06/2012 | US20120309698 HIV Integrase Inhibitors |
| 12/05/2012 | CN101381390B Synthetic method of bromamines muscle relaxant |
| 11/28/2012 | EP2526194A1 Methods for intracellular delivery of nucleic acids |
| 11/28/2012 | CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 11/28/2012 | CN102796160A 17ss-hsd1 and sts inhibitors |
| 11/22/2012 | WO2012157130A1 Method for differentiating adenoma of primary aldosteronism and method for determining 18-oxocortisol (18-oxof) and 18-hydroxycortisol (18-ohf) |
| 11/14/2012 | CN101993470B Process for preparing high-purity rocuronium |
| 11/08/2012 | WO2012083112A3 C- 17 -heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 |
| 11/08/2012 | US20120282331 Mammalian metabolites of steroids |
| 11/07/2012 | CN102372762B Novel technology for synthesizing pregnene 11-site beta-hydroxy |
| 11/01/2012 | WO2012145888A1 Method for purifying rocuronium bromide |
| 10/25/2012 | US20120269725 Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer |
| 10/24/2012 | CN102753565A Progesterone receptor antagonists |
| 10/17/2012 | CN102731605A Purifying method for abiraterone acetate |
| 10/17/2012 | CN102030798B Purification method of abiraterone acetate |
| 10/11/2012 | US20120258941 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 10/10/2012 | CN101044155B Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 10/04/2012 | US20120253032 Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| 10/03/2012 | CN102702297A Preparation method of cholic acid-naphthalimide compound |
| 10/03/2012 | CN102079771B Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof |
| 10/03/2012 | CN101891791B Derivate for labeling bile acid and reference compound, preparation method and application thereof |
| 09/27/2012 | US20120245110 Vascular leakage inhibitor |
| 09/26/2012 | CN102690313A Cholic acid-naphthoylimine compounds and application thereof |
| 09/25/2012 | US8273706 Isobarically labeled analytes and fragment ions derived therefrom |
| 09/25/2012 | CA2512310C Improved linkers for radiopharmaceutical compounds |
| 09/20/2012 | US20120238740 Non-polar and polar leaving groups |
| 09/20/2012 | US20120238488 Compounds and methods for treating neoplasia |
| 09/19/2012 | EP2499151A2 Mammalian metabolites of steroids |
| 09/19/2012 | CN102686600A Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| 09/19/2012 | CN102675402A 4, 16 beta-diamido-steroid quaternary ammonium salt derivatives, and preparation method and application thereof |
| 09/19/2012 | CN102675401A Preparation of anti-tumor medicine LQC-Y and application thereof |
| 09/19/2012 | CN102675400A 3, 16 beta-diamido-steroid quaternary ammonium salt derivatives, and preparation method and application thereof |
| 09/13/2012 | WO2012119458A1 Synthesis and use of antitumor drug lqc-y |
| 09/13/2012 | US20120232042 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases |
| 09/12/2012 | CN102659896A Purification method of capsimine |
| 09/12/2012 | CN101506221B Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
| 09/12/2012 | CN101189251B 17 beta-HSD1 and STS inhibitors |
| 09/05/2012 | CN102286053B Pregnenolone pyrrole compound and preparation method thereof |
| 09/04/2012 | US8258328 Method and intermediates for preparing 19-norsteroid compounds |
| 08/15/2012 | EP2485770A2 Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| 08/08/2012 | CN1439375B Dehydroepiandrosterone treating use and transfer system |
| 08/08/2012 | CN102627682A Esterified and halogenated stigmasterol derivate and application thereof in anti-cancer drugs |
| 08/08/2012 | CN102627681A Preparation method of abiraterone acetate |
| 08/08/2012 | CN102167718B 16-imidazole substitute-3amine substitute-5 alpha androstane derivatives and preparation method and application thereof |
| 08/07/2012 | US8236946 Process for the preparation of 17-0-vinyl-triflates as intermediates |
| 08/02/2012 | WO2012100411A1 Preparation method of rocuronium |
| 08/02/2012 | US20120196842 Certain chemical entities, compositions, and methods |
| 07/26/2012 | US20120190660 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseases |
| 07/26/2012 | US20120190659 Angiogenesis inhibitors |
| 07/25/2012 | CN102603850A Vecuronium bromide compound and production method thereof |
| 07/19/2012 | US20120184515 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases |
| 07/12/2012 | US20120177634 Demethylpenclomedine analogs and their use as anti-cancer agents |
| 07/11/2012 | CN102558276A Non-sizing pipecuronium and preparation method and purpose thereof |
| 07/11/2012 | CN102558275A Alpha type polycrystalline abiraterone acetate crystal, and preparation method, application and pharmaceutical composition thereof |
| 07/11/2012 | CN102558274A Synthetic method applicable to industrial production of Abiraterone acetate |
| 07/05/2012 | US20120172336 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations |
| 07/04/2012 | CN102532237A Camptothecin tenth-position cholic acid coupling compound and preparation method thereof |
| 07/04/2012 | CN102532236A Steroid 5Alpha-reductase inhibitors, preparation methods thereof and medical applications thereof |
| 07/04/2012 | CN102532235A Bufogenin derivative and preparation method thereof, composition containing bufogenin derivative and applications thereof |
| 06/27/2012 | CN102516347A Camptothecin 20-site cholic acid derivative and preparation method thereof |
| 06/27/2012 | CN101712713B Steroid cholic acid-quinacridone derivative and gel thereof |
| 06/27/2012 | CN101307088B Method for preparing cholic acid conjugates |
| 06/21/2012 | WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors |
| 06/21/2012 | US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes |
| 06/21/2012 | CA2819515A1 Cyp11b, cyp17, and/or cyp21 inhibitors |
| 06/14/2012 | US20120149894 Novel cationic lipids with various head groups for oligonucleotide delivery |
| 06/13/2012 | EP2461814A2 Treatment of prostate cancer |